Prognostic Value of Immunocytologic Detection of Bone Marrow Metastases in Neuroblastoma

Open Access

24 January 1991

journal article
research article
Published by Massachusetts Medical Society in New England Journal of Medicine

Vol. 324 (4) , 219-226
https://doi.org/10.1056/nejm199101243240403

Abstract

Morphologic evaluation of bone marrow for neuroblastoma cells is a routine and important component of clinical staging. Specific immunostaining of malignant cells with monoclonal antibodies should be more sensitive, however, and may improve the detection of metastases and provide additional prognostic information.

Keywords

This publication has 29 references indexed in Scilit:

Immunodetection of small cell lung cancer metastases in bone marrow using three monoclonal antibodies
European Journal of Cancer and Clinical Oncology, 1988
Association of Multiple Copies of the N-mycOncogene with Rapid Progression of Neuroblastomas
New England Journal of Medicine, 1985
A Method of Detecting Neuroblastoma in Human Bone Marrow by Means of Two Monoclonal Antibodies PI 153/3 and KE2
Hybridoma, 1985
Detection of bone marrow involvement by neuroblastoma: Comparison of two cytological methods
European Paediatric Haematology and Oncology, 1985
Cellular DNA Content as a Predictor of Response to Chemotherapy in Infants with Unresectable Neuroblastoma
New England Journal of Medicine, 1984
DETECTION OF MICROMETASTASES IN PATIENTS WITH PRIMARY BREAST CANCER
The Lancet, 1983
RAISED NEURON-SPECIFIC ENOLASE IN SERUM OF CHILDREN WITH METASTATIC NEUROBLASTOMA
The Lancet, 1983
Detection of Neuroblastoma Cells in Human Bone Marrow Using a Combination of Monoclonal Antibodies
Hybridoma, 1982
Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures.
Journal of Histochemistry & Cytochemistry, 1981
Incidence of malignant tumors in U.S. children
The Journal of Pediatrics, 1975